Skip to main content

Lupin

Lupin Limited is an Indian pharmaceutical company engaged in the research, development, and global commercialization of branded and generic formulations. The company operates in key segments including generic pharmaceuticals, active pharmaceutical ingredients (APIs), and specialty therapeutics. Its product offerings span therapeutic categories such as anti-tuberculosis, respiratory, cardiovascular, diabetes, central nervous system, and anti-infective medications. Revenue is driven primarily by generic prescription drug sales across the United States, India, Europe, and emerging international markets. Lupin holds a major market position as one of the leading generic pharmaceutical companies based in India. The company is headquartered in Mumbai, India, and its shares are listed on the National Stock Exchange of India and BSE Limited.

21 of the funds FundTelligence covers report a position in Lupin.

Legal name
LUPIN
Sector
Health Care
Country
India
Funds holding it
21

Funds holding Lupin

Showing the 8 largest of 21 funds holding it.

Loading...